上海雅吉生物科技有限公司
首页 产品目录 产品目录(简版) 公司动态 企业认证 企业体检 公司相册 联系我们

文献引用产品:永生化人骨髓间充质干细胞

发布人:上海雅吉生物科技有限公司

发布日期:2026/4/7 8:25:27

文章标题:KIAA1429 promotes the malignancy of oral squamous cell carcinoma by regulating CA9 m6A methylation

作者列表:Tu Jia, Feng Xiao, Cao Qingqing, Guan Yan
期刊:CYTOTECHNOLOGY
发表时间:2024-7-9
影响因子:2
DOI:10.1007/s10616-024-00640-3
主要研究成果:Abstract
KIAA1429 has been reported as a cancer regulator, but its role and mechanism in the progression of oral squamous cell carcinoma (OSCC) remain elusive. The objective of the present research was to figure out the effect of KIAA1429 regulated CA9 on the progression of OSCC. Using qRT-PCR and bioinformatics analysis, we studied the expression levels of KIAA1429 and CA9 in OSCC tissue samples. The functional roles of KIAA1429 and CA9 were assessed using transwell and CCK-8 assays. The regulation among KIAA1429 and CA9 was investigated using MeRIP and western blotting assays. In addition, the m6A level in OSCC was measured utilizing RNA m6A quantification. In OSCC, KIAA1429 and m6A levels were upregulated. We observed that KIAA1429 inhibition declined proliferation, migration, and invasion of OSCC cells and decreased cell growth in vivo. Furthermore, KIAA1429 serves as a crucial upstream regulator of CA9 in OSCC and upregulates CA9 expression through an m6A-dependent mechanism. We observed that CA9 was upregulated in OSCC samples and that low expression of KIAA1429 partially restored the enhanced malignant phenotype caused by CA9 overexpression. Overall, our findings suggest that KIAA1429 and CA9 act as pro-oncogenic factors in OSCC, with KIAA1429 promoting OSCC malignancy through m6A modification-dependent stabilization of CA9 transcripts, which represents a novel regulatory mechanism in OSCC.


相关新闻资讯

新品推荐:嗜肺巴斯德杆菌PCR试剂盒

2026/04/11

产品及特点嗜肺巴斯德杆菌PCR试剂盒可用于检测嗜肺巴斯德杆菌.嗜肺巴斯德杆菌(Pasteurella pneumophila)在自 然界中分布广泛,它有两种生物型,主要感染啮齿类动物,对实验小鼠 大鼠和豚鼠的危 害较大.嗜肺巴斯德杆菌作为一种条件致病菌,能够引起免疫缺陷动物或免疫功能低下的 动物产生严重的肺炎,并可能导致动物死亡.本产品是根据 PCR 原理开发的嗜肺巴斯德 杆菌检测试剂盒,它具有下

细胞基因敲击编辑服务——雅吉生物

2026/04/11

基因编辑全方位解决方案限时特惠  🚀 三大核心服务 助力科研突破**  1️⃣ 基因敲除(KO)服务**  - CRISPR-Cas9大片段敲除**:彻底消除基因功能,无残留背景  - 现货细胞株**:千种常见靶点,低至4980元,2周交付  - 定制服务**:300+创新靶点,8800元起,5-8周完成  - 特色技术**:采用Cas9X系统,编辑效率>90%,脱靶率<0.1%  2️⃣ 基因

新品推荐:ANKRD45(人类)重组蛋白(P01)

2026/04/11

英文名字:ANKRD45 (Human) Recombinant Protein (P01)背景资料:提供的ANKRD45人源重组蛋白(P01)产品为带有GST标签的人源ANKRD45全长序列重组蛋白,其对应的GeneID号为339416.产品描述:与其它公司提供的重组蛋白不同,该ANKRD45人源全长重组蛋白(P01)产品为采用CFS的无细胞麦胚蛋白合成系统表达出来的重组蛋白,可表达出对细胞有毒